Rho Announces New Business Segment


Applied Clinical Trials

Rho, a full-service CRO, announced a new Regulatory Strategy and Submissions business segment which will support their continued growth in helping sponsors plan, develop, and submit marketing applications. The new segment provides an integrated approach for regulatory, clinical, nonclinical, CMC, and statistical experts to work with clients.

Read the full release here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.